http:// Approx. 20 Min
Aug. 28, 2020
Dr. Horowitz on Lyme Disease Treatment
Effect of Dapsone alone and in combination with intracellular antibiotics against the resistant morphological forms of Borrelia burgdorferi, Richard Horowitz, MD
- Also see: https://www.mdpi.com/2079-6382/9/11/725 Case study of 3 patients with relapsing and remitting Lyme disease as well as a retrospective chart review of 37 additional patients undergoing DDD CT therapy (40 patients in total) was also performed, which demonstrated tick-borne symptom improvements in 98% of patients, with 45% remaining in remission for 1 year or longer.
For more:
- https://madisonarealymesupportgroup.com/2020/10/01/new-dapsone-study-breaking-biofilm/
- https://madisonarealymesupportgroup.com/2020/06/26/new-treatments-for-lyme-disease-on-the-horizon/
- https://madisonarealymesupportgroup.com/2016/05/09/leprosy-drug-for-lyme/
- https://madisonarealymesupportgroup.com/2016/10/09/mycobacterium-drugs-for-ld/
- https://madisonarealymesupportgroup.com/2020/11/03/success-of-prescription-alternative-medicine-lyme-treatments/
- https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/
- https://madisonarealymesupportgroup.com/2020/10/14/peer-reviewed-study-confirms-what-we-knew-all-along-longer-antibiotic-treatment-duration-is-associated-with-better-treatment-response-for-lyme-disease/
